Democratic Republic of the Congo Ebola outbreak declared over, Uganda boosted response
On Sept. 17, 2022, the Democratic Republic of the Congo declared the end of an Ebola outbreak that…
On Sept. 17, 2022, the Democratic Republic of the Congo declared the end of an Ebola outbreak that…
On Aug. 23, 2022, Health authorities in the Democratic Republic of the Congo declared a resurgence of Ebola…
On Jul. 17, 2022, Ghana announced the preliminary finding of two cases of Marburg virus disease and if…
On Jul. 7, 2022, Ghana has announced the preliminary finding of two cases of Marburg virus disease and…
On Jul. 4, 2022, the Democratic Republic of the Congo declared the end of the Ebola outbreak that…
On May 18, 2022, the U.S. National Institutes of Health announced it had awarded approximately $577 million to…
On Apr. 28, 2022, the Ministry of Health of the Democratic Republic of the Congo declared an outbreak…
On Dec. 16, 2021, the Ebola outbreak that erupted in the Democratic Republic of the Congo’s North Kivu…
On Nov. 11, 2021, the University of Oxford began recruiting for a Phase I trial to test an…
On Oct. 13, 2021, the Ministry of Health of the Democratic Republic of the Congo announced that vaccination…
On Oct. 8, 2021, the Ministry of Health of the Democratic Republic of the Congo announced that a…
On Aug. 14, 2021, the Ministry of Health of Cote d’Ivoire confirmed the country’s first case of Ebola…
On Aug. 9, 2021, health authorities in Guinea confirmed a case of Marburg virus disease in the southern…
On Jun. 19, 2021, the Ebola outbreak that emerged in Guinea in mid-February was declared over. It was…
On May 3, 2021, the World Health Organization (WHO) announced the end of the 12th Ebola outbreak in…
On Apr. 19, 2021, Tonix Pharmaceuticals and OyaGen announced an exclusive worldwide licensing agreement for an antiviral inhibitor…
On Feb. 14, 2021, the WHO announced that Health authorities in Guinea had declared an outbreak of Ebola…
On Dec. 21, 2020, the U.S. National Institutes of Health (NIH) announced a study published in the Proceedings…
On Nov. 18, 2020, marks the end of the 11th Ebola outbreak in the Democratic Republic of the…
On Oct. 14, 2020, the U.S. Food and Drug Administration (FDA) approved Regeneron Pharmaceutical’s Inmazeb (atoltivimab, maftivimab, and…
On Oct. 14, 2020, Regeneron announced that the U.S. Food and Drug Administration (FDA) had approved Inmazeb (atoltivimab,…
On Aug. 26, 2020, researchers announced an inexpensive, sensitive, CRISPR-based tests diagnose two deadly viruses in settings with…
On Jul. 29, 2020, Regeneron announced that the Biomedical Advanced Research and Development Authority (BARDA) had entered into…
On Jul. 1, 2020, Johnson & Johnson announced that its Janssen Pharmaceutical subsidiary received a positive opinion from…
On Jul. 1, 2020, Johnson & Johnson announced that its Janssen Pharmaceutical subsidiary received a positive opinion from…
On Jun. 25, 2020, the World Health Organization (WHO) announced the end of the 10th outbreak of Ebola…
On Jun. 9, 2020, genetic sequence analysis by the Democratic Republic of the Congo’s (DRC) National Institute of…
On Jun. 1, 2020,The Government of the Democratic Republic of the Congo announced that a new outbreak of…
On May 29, 2020, Johnson & Johnson announced that its Janssen Pharmaceutical subsidiary received a positive opinion from…
On Apr. 30, 2020, BioSig Technologies announced that an article titled, ‘The IMPDH inhibitor merimepodib has similar antiviral…